Adam is a Global Practice Lead and Partner at Prescient. A health economist by training, he has 25 years of global pricing and market access experience in consulting and the pharmaceutical industry, including roles at Aventis, GlaxoSmithKline and Baxter Healthcare. He is an expert in healthcare policy relating to pricing, reimbursement, and patient access to medicines for rare diseases and oncology.